IDEAYA Biosciences (IDYA)
(Delayed Data from NSDQ)
$42.39 USD
+0.10 (0.24%)
Updated Jul 26, 2024 04:00 PM ET
After-Market: $42.31 -0.08 (-0.19%) 7:58 PM ET
2-Buy of 5 2
F Value F Growth A Momentum F VGM
Earnings News For IDYA
-
IDEAYA Biosciences, Inc. Reports First Quarter 2024 Financial Results and Provides Business Update
-
IDEAYA Biosciences, Inc. Reports Fourth Quarter and Full-Year 2023 Financial Results and Provides Business Update
-
IDEAYA Biosciences, Inc. (IDYA) Reports Q3 Loss, Lags Revenue Estimates
-
IDEAYA Biosciences, Inc. Reports Third Quarter 2023 Financial Results and Provides Business Update
-
IDEAYA Biosciences, Inc. (IDYA) Reports Q2 Loss, Lags Revenue Estimates
-
IDEAYA Biosciences, Inc. Reports Second Quarter 2023 Financial Results and Provides Business Update
-
IDEAYA Biosciences, Inc. (IDYA) Reports Q1 Loss, Misses Revenue Estimates
-
IDEAYA Biosciences, Inc. Reports First Quarter 2023 Financial Results and Provides Business Update
-
IDEAYA Biosciences, Inc. (IDYA) Expected to Beat Earnings Estimates: Should You Buy?
-
IDEAYA Biosciences, Inc. (IDYA) Reports Q4 Loss, Misses Revenue Estimates
-
IDEAYA Biosciences, Inc. (IDYA) Q3 Earnings and Revenues Beat Estimates
-
IDEAYA Biosciences, Inc. Reports Third Quarter 2022 Financial Results and Provides Business Update
-
IDEAYA Biosciences, Inc. (IDYA) Reports Q2 Loss, Misses Revenue Estimates
-
IDEAYA Biosciences, Inc. Reports Second Quarter 2022 Financial Results and Provides Business Update
-
IDEAYA Biosciences, Inc. (IDYA) Expected to Beat Earnings Estimates: Should You Buy?
-
IDEAYA Biosciences, Inc. (IDYA) Reports Q1 Loss, Tops Revenue Estimates
-
IDEAYA Biosciences, Inc. (IDYA) Reports Q4 Loss, Misses Revenue Estimates
-
Earnings Preview: IDEAYA Biosciences, Inc. (IDYA) Q3 Earnings Expected to Decline
-
IDEAYA Biosciences, Inc. (IDYA) Reports Q2 Loss, Misses Revenue Estimates
-
IDEAYA Biosciences, Inc. (IDYA) Reports Q1 Loss, Misses Revenue Estimates
-
IDEAYA Biosciences, Inc. (IDYA) Reports Q4 Loss, Lags Revenue Estimates
-
IDEAYA Biosciences, Inc. (IDYA) Reports Q2 Loss, Misses Revenue Estimates